Global Spinal Cord Stimulation (SCS) Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
According to our (Global Info Research) latest study, the global Spinal Cord Stimulation (SCS) Devices market size was valued at US$ 2739 million in 2023 and is forecast to a readjusted size of USD 4221 million by 2030 with a CAGR of 6.4% during review period.
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2019 is about 69%, and the proportion is in increasing trend from 2015 to 2019.
Spinal cord stimulation devices are widely used in Hospitals and Ambulatory Surgery Centers. The most proportion of spinal cord stimulation devices is used in Hospitals, and the proportion in 2019 is 71%.
North America is the largest consumption place, with a consumption market share nearly 57.7% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra are the leaders of the industry. And top 3 account for around 79% of the total market share. These existing companies are making investments in several research activities to launch new devices.
This report is a detailed and comprehensive analysis for global Spinal Cord Stimulation (SCS) Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Spinal Cord Stimulation (SCS) Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2019-2030
Global Spinal Cord Stimulation (SCS) Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2019-2030
Global Spinal Cord Stimulation (SCS) Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2019-2030
Global Spinal Cord Stimulation (SCS) Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Spinal Cord Stimulation (SCS) Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Spinal Cord Stimulation (SCS) Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Spinal Cord Stimulation (SCS) Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Rechargeable SCS
Non-Rechargeable SCS
Market segment by Application
Hospitals
Ambulatory Surgery Centers
Major players covered
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spinal Cord Stimulation (SCS) Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Spinal Cord Stimulation (SCS) Devices, with price, sales quantity, revenue, and global market share of Spinal Cord Stimulation (SCS) Devices from 2019 to 2024.
Chapter 3, the Spinal Cord Stimulation (SCS) Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Cord Stimulation (SCS) Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Spinal Cord Stimulation (SCS) Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Spinal Cord Stimulation (SCS) Devices.
Chapter 14 and 15, to describe Spinal Cord Stimulation (SCS) Devices sales channel, distributors, customers, research findings and conclusion.